Literature DB >> 29869226

Role of DCE-MR in predicting breast cancer subtypes.

Marco Macchini1, Martina Ponziani2, Andrea Prochowski Iamurri3, Mirco Pistelli4, Mariagrazia De Lisa4, Rossana Berardi4, Gian Marco Giuseppetti5,6.   

Abstract

OBJECTIVE: The purpose of this retrospective study is to find a correlation between dynamic contrast-enhanced MR features with histological, immunohistochemical and loco-regional characteristics of breast cancer.
MATERIALS AND METHODS: A total of 149 patients with histopathologically confirmed invasive breast carcinoma underwent MR imaging. Histological analysis included: histological features (histological type, necrosis, vascular invasion and Mib-1), immunohistochemical characterization (immunophenotype, receptor status, HER2-neu and grading) and loco-regional characteristics (T and N). The kinetic MR features analyzed were: curve type, maximum enhancement, time to peak, wash-in and wash-out rate, brevity of enhancement and area under curve.
RESULTS: MRI kinetic parameters and immunohistological features were compared using chi square test, two-tailed student t test and Anova test, with p = 0.05 level of significance. Vascular invasion was shown to be significantly related to time to peak (p = 0.02). The immunohistotype was shown to be significantly related with maximum enhancement (p = 0.05), time to peak (p = 0.04) and wash-in rate (p = 0.01). ER status correlates with maximum and relative enhancement (p = 0.004 and p = 0.028), wash-in rate (p = 0.0018) and area under curve (p = 0.006). PR status was significantly related to time to peak (p = 0.048) and wash-in rate (p = 0.05).
CONCLUSION: Maximum enhancement absolute and relative, time to peak, wash-in rate and area under the curve significantly correlate with several prognostic factors, like ER status, immune profile and tumoral vascular invasion, and may predict the aggressiveness of the tumor.

Entities:  

Keywords:  Breast MRI; Breast cancer; Breast cancer subtypes; Magnetic resonance imaging

Mesh:

Substances:

Year:  2018        PMID: 29869226     DOI: 10.1007/s11547-018-0908-1

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  33 in total

1.  Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.

Authors:  Amanda I Phipps; Christopher I Li; Karla Kerlikowske; William E Barlow; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 2.  Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis.

Authors:  L Wang; I C Van den Bos; S M Hussain; P M Pattynama; M W Vogel; G P Krestin
Journal:  Acta Radiol       Date:  2008-02       Impact factor: 1.990

3.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

4.  Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers.

Authors:  Nita Amornsiripanitch; Vicky T Nguyen; Habib Rahbar; Daniel S Hippe; Vijayakrishna K Gadi; Mara H Rendi; Savannah C Partridge
Journal:  J Magn Reson Imaging       Date:  2017-11-27       Impact factor: 4.813

Review 5.  Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.

Authors:  Gulisa Turashvili; Jan Bouchal; George Burkadze; Zdenek Kolár
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2005-06       Impact factor: 1.245

6.  Tumour size predicts long-term survival among women with lymph node-positive breast cancer.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

Review 7.  Patterns of enhancement on breast MR images: interpretation and imaging pitfalls.

Authors:  Katarzyna J Macura; Ronald Ouwerkerk; Michael A Jacobs; David A Bluemke
Journal:  Radiographics       Date:  2006 Nov-Dec       Impact factor: 5.333

8.  The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.

Authors:  Aparna Suryadevara; Lakshmi P Paruchuri; Nassim Banisaeed; Gary Dunnington; Krishna A Rao
Journal:  World J Surg Oncol       Date:  2010-06-21       Impact factor: 2.754

9.  Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?

Authors:  Ji Youn Kim; Sung Hun Kim; Yun Ju Kim; Bong Joo Kang; Yeong Yi An; A Won Lee; Byung Joo Song; Yong Soo Park; Han Bi Lee
Journal:  Magn Reson Imaging       Date:  2014-08-29       Impact factor: 2.546

10.  Prediction of low-risk breast cancer using perfusion parameters and apparent diffusion coefficient.

Authors:  Hee Jung Shin; Hak Hee Kim; Ki Chang Shin; Yoo Sub Sung; Joo Hee Cha; Jong Won Lee; Byung Ho Son; Sei Hyun Ahn
Journal:  Magn Reson Imaging       Date:  2015-10-30       Impact factor: 2.546

View more
  4 in total

1.  Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).

Authors:  Francesco Amato; Giulia Bicchierai; Donatello Cirone; Catherine Depretto; Federica Di Naro; Ermanno Vanzi; Gianfranco Scaperrotta; Tommaso Vincenzo Bartolotta; Vittorio Miele; Jacopo Nori
Journal:  Radiol Med       Date:  2019-11-26       Impact factor: 3.469

2.  Quantitative Parameters of Diffusion Spectrum Imaging: HER2 Status Prediction in Patients With Breast Cancer.

Authors:  Chunping Mao; Wei Jiang; Jiayi Huang; Mengzhu Wang; Xu Yan; Zehong Yang; Dongye Wang; Xiang Zhang; Jun Shen
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

Review 3.  Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.

Authors:  Toshiki Kazama; Taro Takahara; Jun Hashimoto
Journal:  Life (Basel)       Date:  2022-03-28

4.  Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer.

Authors:  Ma-Yi-di-Li Ni-Jia-Ti; Di-Li-A-Re-Mu Ai-Hai-Ti; Ai-Si-Ka-Er-Jiang Huo-Jia; Pa-Li-Dan-Mu Wu-Mai-Er; A-Bu-du-Ke-You-Mu-Jiang A-Bu-Li-Zi; Yu Shi; Nu-Er-A-Mi-Na Rou-Zi; Wen-Jing Su; Guo-Zhao Dai; Mai-He-Mi-Ti-Jiang Da-Mo-la
Journal:  BMC Cancer       Date:  2020-02-03       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.